BALTAKO
ActiveSummary
BALTAKO has been active since 2021 and the Belgian State Gazette contains no insolvency or warning signals. The 2024 annual accounts show equity of €148k and a net result of €48k. Equity is growing by ~46.2% per year across the filed fiscal years. Its solvency ranks better than 95% of 19913 sector peers (fiscal year 2024). The computed 12-month bankruptcy probability is 0.3% (very low).
Checked score
Score 2024
Axes · tick = 2023
Profitability100=
Solvency100=
Growth52=
Track record94
Bankruptcy probability, 12 months
0.3%
Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €14k at 30 days acceptable
Liquidity ample (current ratio 31.8 against 9.86 in 2023; short-term debt: 3.1% and cash: 79.5% of total assets), and 3.1% of the assets are financed with debt.
Credit check for your own amount and term
Signals
Four signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 86
Relative position
BE, all sectors
reference
Human health activities (NACE 86)
about 87% fewer bankruptcies
← fewer bankruptcies
more bankruptcies →
raises risk · Limited track record
This company has not been active as long as an established one and statistically fails somewhat more often.
KBO · incorporation dateAge against the risk zone
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2024 was due by 31-07-2025 and was filed on 15-05-2025, 77 days ahead of the deadline.
NBB · 3 filingsDeviation from the deadline
2025
not confirmed
2024
77 d early
2023
100 d early
2022
5 d early
← before the deadline
after the deadline →
Checked, nothing found (1)
Financials · fiscal year 2024, micro schema
Equity
€148k▲ 48.3%
2023 · €100k
Total assets
€153k▲ 37.6%
2023 · €111k
Net result
€48k▲ 9.5%
2023 · €44k
Working capital
€148k▲ 48.3%
2023 · €100k
Trend over the years
Click a name to add, emphasise or remove a line.
Every figure with its change against the fiscal year before
favourable
unfavourable
Line202220232024
Operating result€67k-€56k▼ 16.1%€61k▲ 8.6%
Net result€53k-€44k▼ 16.8%€48k▲ 9.5%
Equity€56k-€100k▲ 78.8%€148k▲ 48.3%
Total assets€71k-€111k▲ 57.4%€153k▲ 37.6%
Debt€15k-€11k▼ 23.7%€5k▼ 57.4%
Working capital€56k-€100k▲ 78.8%€148k▲ 48.3%
Turnover and EBIT margin not published: the micro schema does not require them.
Result per fiscal year
Operating resultNet result
The operating result recovers in 2024; 2024 is 9% above 2023.
Balance-sheet composition
2024 in colour, 2023 as the grey bar beneath
Equity and liabilities €153k
Equity
€148k ▲ 48.3%
Debt
€5k ▼ 57.4%
Debt's share of the balance-sheet total falls from 10.1% to 3.1%. Equity is higher and debt is lower.
Key figures and ratios
Current ratio
31.80▲
2023 · 9.86
Debt to equity
0.03▼
2023 · 0.11
ROE
32.6%▼
2023 · 44.1%
ROA
31.5%▼
2023 · 39.6%
Debt ≤ 1 year
€5k▼
2023 · €11k
Income taxes
€13k▲
2023 · €12k
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.
Annual accounts
| Line | 2022 | 2023 | 2024 | Change |
|---|---|---|---|---|
| Other operating charges640/8 | €2k | €2k | €910 | ▼ 57.7% |
| Gross operating margin9900 | €69k | €58k | €62k | ▲ 6.2% |
| Operating profit (loss)9901 | €67k | €56k | €61k | ▲ 8.6% |
| Financial income75/76B | €673 | €1k | €2k | ▲ 42.9% |
| Recurring financial income75 | €673 | €1k | €2k | ▲ 42.9% |
| Financial charges65/66B | €579 | €1k | €1k | ▼ 3.7% |
| Recurring financial charges65 | €579 | €1k | €1k | ▼ 3.7% |
| Profit (loss) for the period before taxes9903 | €67k | €56k | €61k | ▲ 9.6% |
| Income taxes67/77 | €14k | €12k | €13k | ▲ 9.7% |
| Profit (loss) for the period9904 | €53k | €44k | €48k | ▲ 9.5% |
| Profit (loss) for the period to be appropriated9905 | €53k | €44k | €48k | ▲ 9.5% |
| Line | 2022 | 2023 | 2024 | Change |
|---|---|---|---|---|
| Assets | ||||
| Total assets20/58 | €71k | €111k | €153k | ▲ 37.6% |
| Current assets29/58 | €71k | €111k | €153k | ▲ 37.6% |
| Amounts receivable within one year40/41 | €16k | €23k | €31k | ▲ 33.2% |
| Other amounts receivable41 | €16k | €23k | €31k | ▲ 33.2% |
| Cash at bank and in hand54/58 | €54k | €88k | €122k | ▲ 38.2% |
| Deferred charges and accrued income490/1 | €338 | €274 | €843 | ▲ 207% |
| Equity and liabilities | ||||
| Total equity and liabilities10/49 | €71k | €111k | €153k | ▲ 37.6% |
| Equity10/15 | €56k | €100k | €148k | ▲ 48.3% |
| Contributions10/11 | €3k | €3k | €3k | = |
| Reserves13 | €52k | €96k | €145k | ▲ 51.0% |
| Distributable reserves133 | €52k | €96k | €145k | ▲ 51.0% |
| Profit (loss) carried forward14 | €932 | €991 | €257 | ▼ 74.1% |
| Amounts payable17/49 | €15k | €11k | €5k | ▼ 57.4% |
| Amounts payable within one year42/48 | €15k | €11k | €5k | ▼ 57.4% |
| Trade debts44 | €3k | €3k | €4k | ▲ 41.5% |
| Suppliers440/4 | €3k | €3k | €4k | ▲ 41.5% |
| Taxes, remuneration and social security45 | €11k | €9k | €1k | ▼ 86.0% |
| Taxes450/3 | €9k | €6k | €1k | ▼ 80.2% |
| Remuneration and social security454/9 | €2k | €3k | €0 | ▼ 100% |
| Line | 2022 | 2023 | 2024 | Change |
|---|---|---|---|---|
| Profit (loss) for the period9904 | €53k | €44k | €48k | ▲ 9.5% |
| Operating cash flow (approximation) | €53k | €44k | €48k | ▲ 9.5% |
| Change in cash | - | €34k | €34k | ▼ 0.7% |
Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.
Timeline · acts, filings and financial milestones
2025
15-05
NBB filing
Annual accounts filed
fiscal year 2024 · micro schema
2024
31-12
Financial
Liquidity triplescurrent ratio 31.80
Current ratio from 9.86 to 31.80; short-term debt falls from €11k to €5k.
31-12
Financial
Equity above €100kEq €148k ▲48.3%
3 profitable years in a row build equity to €148k.
22-04
NBB filing
Annual accounts filed
fiscal year 2023 · micro schema
2023
31-12
Financial
Weakest financial yearnet €44k ▼16.8%
Net result drops to €44k, the lowest in the series; recovery starts the following year.
31-12
Financial
Liquidity doublescurrent ratio 9.86
Current ratio from 4.78 to 9.86; short-term debt falls from €15k to €11k.
26-07
NBB filing
Annual accounts filed
fiscal year 2022 · micro schema
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
0 of 1 act read
About the unread acts
We know of 1 Belgian State Gazette act for this company. It has not been read yet: what they contain is neither established nor disproved here.
Have them read with priority
Sign in to place this company at the front of the reading queue.
Directors · office · real estate
Directors
1 act for this company is in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Vorst · 1 establishment unit since 2021
Ground area
259 m²
Building footprint
72 m²
Volume, LiDAR
717 m³
Parcel 21007A0102/00B006, Brussels · tallest building 16.4 m, ±4 floors. Linked by address, not a title deed.
1 establishment unit
BALTAKO
since 20212.324.483.848
1 parcel
Brussels
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 21007A0102/00B006 | Brussels | 259 m² | 1 · 72 m² | 16.4 m · 4 fl. |
Linked by address, not proof of ownership
Good to know
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Similar companies · same sector, comparable size
DE BRABANDERE HELEEN
BE 0687.537.879
Staden · Eq €148,271
CABINET DOCTEUR VANMANSART
BE 0748.924.033
Brugelette · Eq €148,231
Dokter Hélène Vlerick huisarts
BE 0778.613.159
Gent · Eq €148,482
DR.Ph. THIEFFRY
BE 0671.457.952
Sint-Pieters-Woluwe · Eq €148,004
Medisch huis Het Laar
BE 0798.707.007
Rumst · Eq €147,955
Of 9,125 companies in sector 86210 we hold annual accounts for 6,336. 5,456 are within a factor 10 of this equity. The 5 above are the closest to it. See the whole sector
Identification & contact
Identification
Legal formPrivate limited company
Founded25-11-2021
Fiscal year end31-12
Activities, NACEBEL 2025
86210General medical practice
Scores and ratios are computed by Checked and are not a credit decision.